Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy

Summary

The purpose of the CAPABLE study is to compare health-related quality of life in renal cell carcinoma patients who use or do not use a mobile-based application to monitor adverse events for cancer treatment at home. As secondary objectives, the study investigates the usability of the system and its generalizability to other cancer types

Conditions

• Renal Cell Carcinoma Metastatic
• Breast Cancer
• Head and Neck Cancer
• Thyroid Cancer
• Ovary Cancer
• Lung Cancer
• Stomach Cancer

Interventions

DEVICE

CAPABLE cohort

The CAPABLE cohort receives the mobileapplication and a multi-sensorial smartwatch (ASUS VivoWatch 5 HC-B05). Patients will be asked to use the system for at least 6 months. The CAPABLE app serves three main functionalities for the patient: symptom monitoring, information needs fulfilment and interventions to improve mental- and physical wellbeing

Sponsors & Collaborators

• University of Pavia

  collaborator OTHER

• Policlinico di Bari Ospedale Giovanni Paolo XXIII

  collaborator UNKNOWN

• Biomeris srl

  collaborator UNKNOWN

• The Netherlands Cancer Institute NKI

  collaborator UNKNOWN

• University of Haifa

  collaborator OTHER

• Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

  collaborator OTHER

• IBM Research

  collaborator UNKNOWN

• Bitsens JSC

  collaborator UNKNOWN

• Poznań University of Technology

  collaborator UNKNOWN

• Deontics LTD

  collaborator UNKNOWN

• Associazione Italiana Malati di Cancro AIMAC

  collaborator UNKNOWN

• Universidad Politecnica de Madrid

  collaborator OTHER

• Istituti Clinici Scientifici Maugeri SpA

  lead OTHER

Study Design

Allocation

NA

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2023-05-16

Primary Completion

2024-01-31

Completion

2024-01-31

Countries

• Italy

Study Locations